Journal Article

Reassessing the Cardiovascular Safety of Febuxostat: Implications of the Febuxostat versus Allopurinol Streamlined Trial

Arthritis and Rheumatology (2021) 73(5) 721-724
DOI: 10.1002/art.41638
21Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.
Get full text

Cite

CITATION STYLE

APA

Choi, H. K., Neogi, T., Stamp, L. K., Terkeltaub, R., & Dalbeth, N. (2021). Reassessing the Cardiovascular Safety of Febuxostat: Implications of the Febuxostat versus Allopurinol Streamlined Trial. Arthritis and Rheumatology, 73(5), 721–724. https://doi.org/10.1002/art.41638

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free